Fig. 3From: Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s diseaseHistograms represent a MMSE scores and b ADCS-ADL and c changes in ADL in placebo versus resveratrol groups in patients treated with placebo (N = 19) or resveratrol (N = 19) for 52 weeks. Mean ± SD, **p < 0.01, ***p < 0.001Back to article page